New Market Research Report: Analgesics in Switzerland

The liberalisation of some analgesics previously only available under prescription or in pharmacies was the most important factor affecting the category in 2014. For example, Ibuprofen which was previously only available in pharmacies, can now be sold in drugstores as well. Besides, the revision of the Therapeutic Products Act in 2014 made it possible for consumers to buy powerful analgesics (such as Ponstan, Aspegic or Dafalgan 1g) in pharmacies without a prescription. This situation has angered the medical profession, which is opposed to this reform.

Competitive Landscape

The two key players in analgesics, Vifor Pharma AG and Bayer (Schweiz) AG, accounted together for a 28% share of value sales in 2014. Vifor Pharma’s leading brand Algifor evolves in the dynamic ibuprofen category and is a popular product in Switzerland. The brand increased its value share over the review period. Bayer (Schweiz) AG’s performance can be attributed to its strong position in aspirin. Third-ranked GlaxoSmithKline benefits from the strong performance of its Panadol brand which is the leading brand in analgesics.

Full Report Details at
- http://www.fastmr.com/prod/981331_analgesics_in_switzerland.aspx?afid=301

Industry Prospects

Analgesics is set to post a value CAGR of 1% at constant 2014 prices to reach sales of CHF224 million over the forecast period. The ageing of the population in Switzerland and the need to treat various affections linked to age are expected to positively impact sales of analgesics. However, the effects of the liberalisation on unit prices and the introduction of more generic products are both expected to offset further category growth.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Switzerland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Switzerland market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

* What is the market size of Analgesics in Switzerland?
* What are the major brands in Switzerland?
* Are combination products with acetaminophen still popular?

Reasons to Get this Report

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Analgesics in Portugal
- Analgesics in Romania
- Analgesics in Japan
- Analgesics in Saudi Arabia
- Analgesics in Denmark